ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

41.69
Delayed Data
As of Jul 02
 +0.02 / +0.05%
Today’s Change
19.21
Today|||52-Week Range
46.48
+31.31%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close41.67
Today’s open41.95
Day’s range41.16 - 42.02
Volume433,901
Average volume (3 months)1,206,884
Market cap$4.2B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-44.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book13.48

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.35-0.73%
GRFSGrifols SA-0.24-0.77%
RAREUltragenyx Pharmaceu...-1.15-1.11%
PBYIPuma Biotechnology I...-0.15-0.13%
Data as of 4:01pm ET, 07/02/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers